Genentech Beats IP Suit Over Breast Cancer Drug Patent
A California federal judge on Thursday tossed Phigenix Inc.'s patent infringement suit against Genentech Inc. over a breast cancer drug, finding no evidence that Genentech encouraged health care professionals to administer...To view the full article, register now.
Already a subscriber? Click here to view full article